S
RGNX icon

SignatureFD’s Regenxbio RGNX Stock Holding History

SignatureFD’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24K Sell
2,000
-20
-1% -$166 ﹤0.01% 2258
2026
Q1 		$16.9K Buy
2,020
+20
+1% +$210 ﹤0.01% 2276
2025
Q4 		$28.8K Hold
2,000
– – ﹤0.01% 1946
2025
Q3 		$19.3K Hold
2,000
– – ﹤0.01% 2128
2025
Q2 		$16.4K Sell
2,000
-460
-19% -$3.85K ﹤0.01% 2147
2025
Q1 		$17.6K Buy
2,460
+377
+18% +$2.8K ﹤0.01% 2119
2024
Q4 		$16.1K Buy
2,083
+83
+4% +$779 ﹤0.01% 2167
2024
Q3 		$21K Buy
+2,000
New +$24.4K ﹤0.01% 2020
2024
Q1 		– Sell
-552
Closed -$9.91K – 3248
2023
Q4 		$9.91K Buy
+552
New +$9.72K ﹤0.01% 2265
2023
Q3 		– Sell
-18
Closed -$360 – 3286
2023
Q2 		$360 Buy
+18
New +$347 ﹤0.01% 3097
2022
Q1 		– Sell
-55
Closed -$2K – 3297
2021
Q4 		$2K Buy
55
+21
+62% +$715 ﹤0.01% 2781
2021
Q3 		$1K Hold
34
– – ﹤0.01% 2900
2021
Q2 		$1K Hold
34
– – ﹤0.01% 2808
2021
Q1 		$1K Hold
34
– – ﹤0.01% 2669
2020
Q4 		$2K Hold
34
– – ﹤0.01% 2301
2020
Q3 		$1K Buy
+34
New +$1.11K ﹤0.01% 2480

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SignatureFD's RGNX Position: Q2 2026 in Review

SignatureFD reduced its Regenxbio (RGNX) stake by 0.99% in Q2 2026, selling an estimated $166 and leaving 2,000 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

SignatureFD first reported a position in RGNX in Q3 2020 and has held it in 16 quarters since. The position peaked at $28.8K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • SignatureFD held 2,000 shares of Regenxbio worth $24K as of Q2 2026.
  • SignatureFD sold 20 Regenxbio shares in Q2 2026, an estimated $166.
  • Regenxbio made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2258 holding.
  • SignatureFD first reported a position in Regenxbio in Q3 2020 and has held it in 16 quarters since.
  • SignatureFD's Regenxbio position peaked at $28.8K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.